| Price | 978.00p on 16-04-2026 at 18:30:07 |
|---|---|
| Change | 14.00p 1.45% |
| Buy | 990.00p |
| Sell | 980.00p |
| Last Trade: | Unknown 500.00 at 978.00p |
| Day's Volume: | 42,200 |
| Last Close: | 978.00p |
| Open: | 966.00p |
| ISIN: | GB0004559349 |
| Day's Range | 966.00p - 990.00p |
| 52wk Range: | 546.00p - 1,000.00p |
| Market Capitalisation: | £311.28m |
| VWAP: | 981.03874p |
| Shares in Issue: | 31.83m |
Sector: Closed End Investments
Listed In: FTSE All-Share, FTSE Small Cap
Int.biotech. (IBT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 500 | 978.00p | OTC Trade |
17:07:19 - 16-Apr-26 |
| Sell* | 788 | 978.00p | Uncrossing Trade |
16:35:13 - 16-Apr-26 |
| Sell* | 200 | 980.33p | Negotiated Trade |
16:15:06 - 16-Apr-26 |
| Sell* | 140 | 981.00p | Negotiated Trade |
15:59:15 - 16-Apr-26 |
| Buy* | 101 | 985.247p | Suspected BUY Trade |
15:58:29 - 16-Apr-26 |
| Sell* | 5 | 980.70p | Ordinary |
15:49:18 - 16-Apr-26 |
| Buy* | 201 | 983.461p | Suspected BUY Trade |
15:46:31 - 16-Apr-26 |
| Buy* | 13 | 982.00p | SI Trade |
15:06:42 - 16-Apr-26 |
| Buy* | 133 | 981.96p | Suspected BUY Trade |
15:03:23 - 16-Apr-26 |
| Buy* | 404 | 981.96p | Suspected BUY Trade |
15:01:20 - 16-Apr-26 |
Int.biotech. (IBT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 15th Apr 2026 11:36 am | RNS | Net Asset Value(s) |
| 14th Apr 2026 11:41 am | RNS | Net Asset Value(s) |
| 13th Apr 2026 11:51 am | RNS | Net Asset Value(s) |
| 10th Apr 2026 4:40 pm | RNS | Compliance with Market Abuse Regulation |
| 10th Apr 2026 12:06 pm | RNS | Net Asset Value(s) |
| 9th Apr 2026 11:32 am | RNS | Net Asset Value(s) |
| 8th Apr 2026 11:50 am | RNS | Net Asset Value(s) |
| 7th Apr 2026 5:15 pm | RNS | Transaction in Own Shares |
| 7th Apr 2026 11:56 am | RNS | Net Asset Value(s) |
| 7th Apr 2026 10:25 am | RNS-R | Portfolio company Soleno acquired by Neurocrine |
